| AFP.com

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant. The Boston-based biotech startup develops AI-designed gene editing therapies for Parkinson’s disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618442937/en/Neoclease receives Merck’s North American Advance Biotech Grant. “We’re committed to empowering biotech innovators who are advancing...

Subscribe to

Taipei,<br /><span style="color: #0083C9;">Taiwan</span>

Sydney,<br /><span style="color: #0083C9;">Australia</span>

Dakar,<br /><span style="color: #0083C9;">Senegal</span>

Strasbourg,<br /><span style="color: #0083C9;">France</span>

Toutes les actualités

Toutes les actualités

Stockholm,<br /><span style="color: #0083C9;">Sweden</span>

Ankara,<br /><span style="color: #0083C9;">Turkey</span>

Asuncion,<br /><span style="color: #0083C9;">Paraguay</span>

Athens,<br /><span style="color: #0083C9;">Greece</span>

About AFP